Eur J Clin Pharmacol 79(9):123948 Mailhac A, Pedersen L, Pottegrd A, Sndergaard J, Mogensen T, Srensen HT et al (2024) Semaglutide (Ozempic) Use in Denmark 2018 through 2023 - user trends and off-label prescribing for weight loss
Research Snapshot: Current State of Research Semaglutide has been examined extensively in GLP-1 receptor pharmacology, glucose-regulation research, appetite and gastric-emptying studies, cardiovascular-outcome research, body-weight trials, kidney-outcome research, and peptide-formulation studies
Some people still see results, but it might take more sessions, or electrolysis might be a better fit
doi: 10.1016/j.clnu.2019.05.004 153 PelliciariSPinatelEVanniniAPeanoCPuccioSDe BellisGet al
But clinically, that doesnt necessarily mean the medication has stopped working